We are leading the field of Regenerative Medicine and setting the gold standard for the next generation of healthcare. Today we are focusing on diseases of the Central Nervous System and we are working with two regenerative medicine solutions :
- Neural DrSC based on a proprietary technology platform for the direct reprogramming of somatic cells to neural precursor cells
- Regeneration MatrixTM (RMxTM) based on a proprietary technology platform for the production of regenerative implants
Somatic cells are the everyday cells that make up our body. Somatic cells are ethical and do not involve the use of any embryonic or fetal cells or other material from these sources. We also use no animal components, viruses or bacteria in our production process.
The technology has been validated by several KOLs, and we have recently been granted US patents on this technology, including composition of matter. Results from various exploratory clinical studies have also been very promising, and we are preparing to start several key clinical trials in 2017 based on this.